Exploitation of alloreactive NK cells in adoptive immunotherapy of cancer
- 30 April 2005
- journal article
- review article
- Published by Elsevier in Current Opinion in Immunology
- Vol. 17 (2), 211-217
- https://doi.org/10.1016/j.coi.2005.01.007
Abstract
No abstract availableKeywords
This publication has 42 references indexed in Scilit:
- Successful adoptive transfer and in vivo expansion of human haploidentical NK cells in patients with cancerBlood, 2005
- Evaluation of KIR ligand incompatibility in mismatched unrelated donor hematopoietic transplantsBlood, 2002
- Natural killer cell receptors: new biology and insights into the graft-versus-leukemia effectBlood, 2002
- Face off — the interplay between activating and inhibitory immune receptorsCurrent Opinion in Immunology, 2001
- Prevention of Graft Versus Host Disease by Inactivation of Host Antigen-Presenting CellsScience, 1999
- REGULATION OF IMMUNE RESPONSES THROUGH INHIBITORY RECEPTORSAnnual Review of Immunology, 1999
- Structure and function of the CD94 C‐type lectin receptor complex involved in recognition of HLA class I moleculesImmunological Reviews, 1997
- The Role of Ly49A and 5E6(Ly49C) Molecules in Hybrid Resistance Mediated by Murine Natural Killer Cells Against Normal T Cell BlastsImmunity, 1996
- Allorecognition by NK cells: nonself or no self?Immunology Today, 1992
- In search of the ‘missing self’: MHC molecules and NK cell recognitionImmunology Today, 1990